Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

Influenza Virus Vaccine for the 2007-2008 Season

2007/2008 Season Lot Release Status (as of December 5, 2007)
Flu vaccine lots that have been released by FDA and are available for distribution by the manufacturers.

For information on flu vaccine distribution schedules, please contact the manufacturers directly.

Manufacturer Total Number of Lots Released by FDA
CSL Limited
Victoria, Australia
License 1764
GlaxoSmithKline Biologicals
Rue de l'Institut 89
B1330 Rixensart Belgium
License 1617
ID Biomedical Corporation of Quebec
525 Cartier Blvd, West
Laval, Quebec 87V 3S8 Canada
License 1739
Novartis Vaccine
Gaskill Road, Speke
Liverpool L24 9GR
United Kingdom
License 1750
Sanofi Pasteur Inc
Discovery Drive
Swiftwater, PA 18370
License 1725
297 North Bernardo Ave
Mountain View, CA 94043
License 1652

FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) met in Gaithersburg, Maryland, on February 28, 2007, to select the influenza virus strains for the composition of the influenza vaccine for use in the 2007-2008 U.S. influenza season. During this meeting, the advisory panel reviewed and evaluated the surveillance data related to epidemiology and antigenic characteristics, serological responses to 2006/2007 vaccines, and the availability of candidate strains and reagents.

The panel recommended that vaccines to be used in the 2007-2008 influenza season in the U.S. contain the following:

  • an A/Solomon Islands/3/2006 (H1N1)-like virus;
  • an A/Wisconsin/67/2005 (H3N2)-like virus;
  • a B/Malaysia/2506/2004-like virus

The influenza vaccine composition to be used in the 2007-2008 influenza season in the U.S. is identical to that recommended by the World Health Organization on February 14, 2007.

Contact FDA

(800) 835-4709
(240) 402-8010
Consumer Affairs Branch (CBER)

Division of Communication and Consumer Affairs

Office of Communication, Outreach and Development

Food and Drug Administration

10903 New Hampshire Avenue

Building 71 Room 3103

Silver Spring, MD 20993-0002

Page Last Updated: 01/26/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English